The YRB30 Antibody (Product Code: CSB-PA344850XA01SVG) targets the YRB30 protein in Saccharomyces cerevisiae. It is produced and validated for research applications, including immunoblotting, immunofluorescence, and immunoprecipitation .
Genetic Interaction Networks: Systematic E-MAP (Epistatic Miniarray Profile) screens in yeast have mapped genetic interactions for GTPase-related proteins (e.g., Gsp1) . While YRB30 is not explicitly mentioned, such methodologies could elucidate its functional partnerships.
Antibody Engineering: Studies on antibody architecture emphasize the importance of epitope valency and spatial orientation for effector cell engagement . Though focused on human therapeutics, these principles inform the design of yeast-targeted antibodies like YRB30.
The YRB30 Antibody’s utility can be contextualized alongside related antibodies:
| Antibody Target | Code | UniProt ID | Key Role |
|---|---|---|---|
| YRB30 | CSB-PA344850XA01SVG | P53107 | Protein trafficking/stress response |
| YRA1 | CSB-PA618573XA01SVG | Q12159 | RNA export |
| YPT31 | CSB-PA336467XA01SVG | P38555 | Vesicular transport |
Data Gaps: Direct functional studies on YRB30 are sparse. Its role in oxidative stress or aneuploidy (e.g., Chromosome IV duplication linked to stress tolerance ) remains speculative.
Technical Advancements: High-resolution mass spectrometry (AP-MS) and genome-wide sequencing could clarify YRB30’s interactome and regulatory networks.
KEGG: sce:YGL164C
STRING: 4932.YGL164C
YRB30 (Uniprot: P53107) is a protein expressed in Saccharomyces cerevisiae (Baker's yeast, strain ATCC 204508 / S288c) . While the specific cellular function of YRB30 requires further investigation, researchers can employ several methodological approaches to characterize its role:
Phenotypic analysis of YRB30 deletion mutants compared to wild-type strains
Protein localization studies using fluorescently tagged YRB30 constructs
Protein-protein interaction analysis via co-immunoprecipitation with YRB30 Antibody
Transcriptomic profiling to identify genes co-regulated with YRB30
Comparative genomic analysis across different yeast species to determine conservation
Based on the product information available, the YRB30 Antibody (CSB-PA344850XA01SVG) has been tested and validated for the following applications :
ELISA (Enzyme-Linked Immunosorbent Assay) for quantitative detection
Western Blotting (WB) for expression analysis and protein characterization
Researchers should note that this antibody is specified for research use only and should not be used for diagnostic or therapeutic purposes . When designing experiments, consideration should be given to appropriate controls, including YRB30 knockout strains, to validate antibody specificity and performance.
Similar to other research antibodies, validation of YRB30 Antibody specificity should follow rigorous protocols. Drawing from established antibody validation methods , researchers should consider:
Testing against wild-type and YRB30 knockout S. cerevisiae strains to confirm specificity
Performing epitope mapping to determine the specific binding region, similar to approaches used for other antibodies
Conducting pre-absorption controls with recombinant YRB30 protein
Analyzing potential cross-reactivity with related yeast proteins via Western blotting
Verifying consistent performance across different experimental conditions and sample preparation methods
Based on the product information, optimal storage conditions for YRB30 Antibody are :
Upon receipt, store at -20°C or -80°C
Avoid repeated freeze-thaw cycles
Additional best practices for antibody handling include:
Aliquoting the antibody stock solution into single-use volumes
Adding preservatives such as sodium azide (0.02%) for longer-term storage of working dilutions
Maintaining detailed records of lot numbers, storage conditions, and experimental performance
Periodically validating antibody performance, especially after prolonged storage
Epitope mapping is crucial for understanding antibody binding characteristics and improving experimental design. For YRB30 Antibody, researchers could employ methods similar to those described for other antibodies :
Deletion Mapping:
Generate nested truncations of the YRB30 protein
Express these constructs as fusion proteins
Perform Western blotting to identify the minimal region recognized
Peptide Array Analysis:
Synthesize overlapping peptides (12-15 amino acids) spanning the YRB30 sequence
Test antibody binding to identify specific linear epitopes
Analyze the resulting data to determine the precise epitope boundaries
Mutational Analysis:
Once a candidate epitope region is identified, create point mutations
Replace individual amino acids with alanine or other residues
Test antibody binding to identify critical residues for recognition
According to related antibody characterization studies, linear epitopes of at most 12 amino acids can be identified and verified by binding to epitope-only peptides , providing a useful methodological framework.
When optimizing YRB30 Antibody for challenging applications, researchers can implement several strategies:
| Optimization Parameter | Methodological Approach | Expected Outcome |
|---|---|---|
| Antibody Dilution | Systematic titration (1:500 to 1:5000) | Optimal signal-to-noise ratio |
| Blocking Conditions | Test different blocking agents (BSA, milk, commercial blockers) | Reduced background |
| Incubation Time | Vary primary antibody incubation (1h to overnight) | Balanced sensitivity and specificity |
| Buffer Composition | Adjust salt and detergent concentrations | Improved signal quality |
| Sample Preparation | Compare different lysis methods | Enhanced antigen accessibility |
These approaches align with best practices in antibody-based applications and can be adapted from protocols used in similar antibody characterization studies .
Post-translational modifications can significantly impact antibody recognition. For YRB30 research, consider:
Common Yeast PTMs and Their Effects:
Phosphorylation may alter protein conformation or charge distribution
Ubiquitination could mask epitopes or change molecular weight
Glycosylation might interfere with antibody accessibility to the epitope
Methodological Approaches for PTM Assessment:
Treat samples with phosphatases or deglycosylation enzymes before antibody application
Compare antibody binding under conditions that promote or inhibit specific PTMs
Use multiple antibodies targeting different epitopes for comprehensive detection
Apply techniques from oxidative stress research to understand PTM dynamics
Data Interpretation Strategies:
Multiple bands on Western blots might indicate different PTM variants
Shifts in apparent molecular weight could suggest specific modifications
Changes in detection efficiency under different conditions might reflect PTM-dependent epitope accessibility
Understanding how YRB30 expression responds to stress is crucial for rigorous experimental design:
Potential Stress Responses to Investigate:
Experimental Design Considerations:
Include time-course experiments to track expression dynamics
Implement dose-response studies to determine threshold effects
Control for unintended stress during sample preparation
Account for potential stress interactions in complex experiments
Design appropriate controls and normalization strategies
Comparative Analysis Approaches:
Relate YRB30 expression patterns to known stress response pathways in yeast
Consider genetic background effects on stress responses
Apply statistical methods to identify significant changes in expression
Integrate findings with broader stress response networks
Computational methods can significantly augment experimental approaches in YRB30 antibody research:
Biophysics-Informed Modeling:
Sequence Analysis Tools:
Identify conserved domains that might influence antibody binding
Compare YRB30 sequences across strains to predict strain-specific variation in antibody performance
Analyze potential post-translational modification sites
Data Integration Approaches:
Combine antibody-derived data with transcriptomic and proteomic datasets
Develop predictive models of YRB30 function based on integrated datasets
Apply machine learning to optimize experimental conditions for antibody use
The integration of computational and experimental approaches has shown significant value in antibody research, allowing for more targeted and efficient experimental design .
When encountering variability in YRB30 Antibody performance, implementing a structured troubleshooting approach is essential:
Antibody-Related Factors:
Evaluate lot-to-lot variability through consistent control experiments
Assess storage conditions and potential degradation
Optimize working dilution for each specific application
Consider antibody age and freeze-thaw history
Sample Preparation Considerations:
Standardize protein extraction methods (detergent types, buffer compositions)
Ensure consistent use of protease and phosphatase inhibitors
Minimize sample handling time and temperature fluctuations
Verify protein denaturation conditions for Western blotting
Systematic Investigation Protocol:
Isolate variables by changing one factor at a time
Document all experimental conditions in detail
Create a standardized positive control sample for long-term use
Validate observations with orthogonal methods when possible
This systematic approach aligns with best practices in antibody research and can help identify specific factors affecting experimental reproducibility.
Establishing robust quality control measures ensures consistent antibody performance over time:
| Quality Control Parameter | Methodological Approach | Acceptance Criteria |
|---|---|---|
| Specificity Validation | Western blot against WT and knockout strains | Single band at expected MW in WT; absent in knockout |
| Sensitivity Assessment | Serial dilution of target protein | Detection at expected lower limit of concentration |
| Reproducibility Testing | Repeated assays with standard samples | Coefficient of variation <15% |
| Cross-Reactivity Profiling | Testing against related proteins | Minimal binding to non-target proteins |
| Lot Comparison | Side-by-side testing of new lots | Comparable performance to reference lot |
These quality control measures draw on approaches used in antibody characterization studies and help maintain experimental consistency throughout a research program.
Integration of YRB30 Antibody-based research with other omics technologies offers numerous opportunities:
Proteogenomics Integration:
Spatial and Temporal Profiling:
Use YRB30 Antibody for immunofluorescence to track subcellular localization
Implement time-course experiments to capture dynamic changes in response to stimuli
Correlate with metabolomic data to connect YRB30 function with cellular metabolic state
Systems Biology Applications:
Map YRB30 into protein interaction networks
Identify regulatory relationships affecting YRB30 expression
Develop predictive models of YRB30 function in cellular pathways
These integrated approaches align with modern trends in systems biology research and offer a more comprehensive understanding of YRB30's role in yeast biology.
Emerging technologies offer exciting possibilities for advancing YRB30 research:
Enhanced Specificity Technologies:
High-Throughput Applications:
Adaptation of YRB30 Antibody for microarray or bead-based multiplex assays
Development of automated image analysis workflows for immunofluorescence studies
Integration with single-cell technologies for cell-to-cell variation analysis
Modified Antibody Formats:
Engineering of recombinant YRB30 antibody fragments for improved tissue penetration
Development of fluorescently tagged direct detection systems
Creation of proximity-labeling antibody derivatives for identifying nearby proteins
These technological advances build upon current antibody research capabilities and represent promising directions for enhancing YRB30-focused studies.